What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?GOBBI, Paolo G; FEDERICO, Massimo.Critical reviews in oncology/hematology. 2012, Vol 82, Num 1, pp 18-24, issn 1040-8428, 7 p.Article

MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma : 10-year results, latetoxicity, and second tumorsGOBBI, Paolo G; BROGLIA, Chiara; PAVONE, Vincenzo et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 529-535, issn 1078-0432, 7 p.Article

Hodgkin lymphomaGOBBI, Paolo G; FERRERI, Andres J. M; PONZONI, Maurilio et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 216-236, issn 1040-8428, 21 p.Article

How I treat enteropathy-associated T-cell lymphomaDI SABATINO, Antonio; BIAGI, Federico; GOBBI, Paolo G et al.Blood. 2012, Vol 119, Num 11, pp 2458-2468, issn 0006-4971, 11 p.Article

The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancerGOBBI, Paolo G; BERGONZI, Manuela; COMELLI, Mario et al.Cancer epidemiology (Print). 2013, Vol 37, Num 2, pp 186-190, issn 1877-7821, 5 p.Article

Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parametersGOBBI, Paolo G; BERGONZL, Manuela; BASSI, Emilio et al.Oncology reports. 2012, Vol 28, Num 3, pp 815-820, issn 1021-335X, 6 p.Article

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma : a 16-year follow-up studySACCHI, Stefano; MARCHESELLI, Luigi; STELITANO, Caterina et al.Haematologica (Roma). 2008, Vol 93, Num 3, pp 398-404, issn 0390-6078, 7 p.Article

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma : Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialFEDERICO, Massimo; LUMINARI, Stefano; SCALONE, Renato et al.Journal of clinical oncology. 2009, Vol 27, Num 5, pp 805-811, issn 0732-183X, 7 p.Article

Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow TransplantationLUIGI ZINZANI, Pier; MARTELLI, Maurizio; TURA, Sante et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1364-1371, issn 0390-6078, 8 p.Article

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma : Final results of a multicenter randomized trial by the Intergruppo Italiano LinfomiGOBBI, Paolo G; LEVIS, Alessandro; LIBERATI, Marina et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9198-9207, issn 0732-183X, 10 p.Article

Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?GOBBI, Paolo G; BALDINI, Luca; BROGLIA, Chiara et al.Clinical cancer research. 2005, Vol 11, Num 5, pp 1786-1790, issn 1078-0432, 5 p.Article

The clinical value of tumor burden at diagnosis in Hodgkin lymphomaGOBBI, Paolo G; BROGLIA, Chiara; PAULLI, Marco et al.Cancer. 2004, Vol 101, Num 8, pp 1824-1834, issn 0008-543X, 11 p.Article

Clinical and biological effects of treatment with amifostine in myelodysplastic syndromesINVERNIZZI, Rosangela; PECCI, Alessandro; TRAVAGLINO, Erica et al.British journal of haematology. 2002, Vol 118, Num 1, pp 246-250, issn 0007-1048Article

Prognostic relevance of serum β2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyFEDERICO, Massimo; GUGLIELMI, Cesare; STELITANO, Caterina et al.Haematologica (Roma). 2007, Vol 92, Num 11, pp 1482-1488, issn 0390-6078, 7 p.Article

Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: The experience of the Gruppo Italiano Studio LinfomiGOBBI, Paolo G; BROGLIA, Chiara; CAVALLI, Carla et al.Cancer. 2003, Vol 98, Num 11, pp 2393-2401, issn 0008-543X, 9 p.Article

Image-aided estimate of tumor burden in Hodgkin's disease : Evidence of its primary prognostic importanceGOBBI, Paolo G; GHIRARDELLI, Maria L; CARNEVALE MAFFE, Gabriella et al.Journal of clinical oncology. 2001, Vol 19, Num 5, pp 1388-1394, issn 0732-183XArticle

Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphomaGOBBI, Paolo G; VALENTINO, Francesco; QUINTANA, Gianni et al.Oncology reports. 2009, Vol 21, Num 4, pp 1029-1035, issn 1021-335X, 7 p.Article

Classical Hodgkin's lymphoma in adults : guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-upBRUSAMOLINO, Ercole; BACIGALUPO, Andrea; BAROSI, Giovanni et al.Haematologica (Roma). 2009, Vol 94, Num 4, pp 550-565, issn 0390-6078, 16 p.Article

Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma : a GISL cohort studySACCHI, Stefano; MARCHESELLI, Luigi; BARI, Alessia et al.Haematologica (Roma). 2008, Vol 93, Num 9, pp 1335-1342, issn 0390-6078, 8 p.Article

Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitorPERFETTI, Vittorio; PALLADINI, Giovanni; BRUNETTI, Laura et al.European journal of gastroenterology & hepatology. 2007, Vol 19, Num 7, pp 599-601, issn 0954-691X, 3 p.Article

Prognostic factors in symptomatic Waldenstrom's macroglobulinemiaMERLINI, Giampaolo; BALDINI, Luca; BROGLIA, Chiara et al.Seminars in oncology. 2003, Vol 30, Num 2, pp 211-215, issn 0093-7754, 5 p.Article

Comparison of Prognostic models in patients with advanced Hodgkin disease: Promising results from integration of the best three systemsGOBBI, Paolo G; ZINZANI, Pier Luigi; BROGLIA, Chiara et al.Cancer. 2001, Vol 91, Num 8, pp 1467-1478, issn 0008-543XArticle